A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(66 sites)

United States

Investigational Site Number: 8400009, Escondido, California

Investigational Site Number: 8400006, Lancaster, California

Investigational Site Number: 8400025, Thousand Oaks, California

Investigational Site Number: 8400024, Jacksonville, Florida

Investigational Site Number: 8400030, Kissimmee, Florida

Investigational Site Number: 8400003, Lighthouse PT, Florida

Investigational Site Number: 8400001, Miami, Florida

Investigational Site Number: 8400011, Miami, Florida

Investigational Site Number: 8400010, Palmetto Bay, Florida

Investigational Site Number: 8400019, Tampa, Florida

Investigational Site Number: 8400018, Marietta, Georgia

Investigational Site Number: 8400005, Iowa City, Iowa

Investigational Site Number: 8400017, Boston, Massachusetts

Investigational Site Number: 8400012, Wyoming, Michigan

Investigational Site Number: 8400014, St Louis, Missouri

Investigational Site Number: 8400021, New York, New York

Investigational Site Number: 8400029, Queens Village, New York

Investigational Site Number: 8400002, Chapel Hill, North Carolina

Investigational Site Number: 8400013, Harrisburg, Pennsylvania

Investigational Site Number: 8400023, Houston, Texas

Investigational Site Number: 8400007, Ogden, Utah

Australia

Investigational Site Number: 0360003, Brisbane, Queensland

Investigational Site Number: 0360001, Clayton, Victoria

China

Investigational Site Number: 1560004, Huizhou, Ghangdong

Investigational Site Number: 1560005, Guangzhou, Guangdong

Investigational Site Number: 1560002, Nanjing, Jiangsu

Investigational Site Number: 1560008, Suzhou, Jiangsu

Investigational Site Number: 1560003, Wuxi, Jiangsu

Investigational Site Number: 1560001, Hangzhou

Investigational Site Number: 1560007, Ningbo

Czechia

Investigational Site Number: 2030001, Brno, JM

Investigational Site Number: 2030002, Slaný

France

Investigational Site Number: 2500002, Lille

Investigative Site: 2500006, Nice

Investigational Site Number: 2500005, Pierre-Bénite

Investigational Site Number: 2500001, Saint-Priest-en-Jarez

Investigational Site Number: 2500003, Toulouse

Investigational Site Number: 2500004, Vandœuvre-lès-Nancy

Germany

Investigational Site Number: 2760001, Minden, Northwest

Investigational Site Number: 2760005, Kiel, Schleswig-Holstein

Investigational Site Number: 2760003, Ulm

Hungary

Investigational Site Number: 3480003, Budapest

Investigational Site Number: 3480002, Budapest

Investigational Site Number: 3480001, Vác

Japan

Investigational Site Number: 3920002, Kashiwa, Chiba

Investigational Site Number: 3920006, Ōita, Oita Prefecture

Investigational Site Number: 3920005, Hamamatsu

Investigational Site Number: 3920003, Hirosaki

Investigational Site Number: 3920001, Morioka

Investigational Site Number: 3920004, Nishinomiya

Moldova

Investigational Site Number: 4980001, Chisinau

Poland

Investigational Site Number: 6160006, Wroclaw, Lower Silesian Voivodeship

Investigational Site Number: 6160002, Bydgoszcz

Investigational Site Number: 6160009, Chojnice

Investigational Site Number: 6160007, Katowice

Investigational Site Number: 6160005, Sopot

Investigational Site Number: 6160008, Tychy

Investigational Site Number: 6160004, Warsaw

Investigational Site Number: 6160003, Warsaw

Investigational Site Number: 6160001, Wroclaw

Spain

Investigational Site Number: 7240001, Las Palmas de Gran Canaria

Investigational Site Number: 7240002, Madrid

United Kingdom

Investigational Site Number: 8260002, Northwich, CHW

Investigational Site Number: 8260003, Bury

Investigational Site Number: 8260001, London

Investigational Site Number: 8260004, London

View full record on ClinicalTrials.gov